Posted inBiotechnology
Posted inBiotechnology
Roche mothballs another hemophilia A gene therapy under Spark amid plans to debut new hematologic asset
Following the apparent elimination of a late-stage gene therapy study last week, Swiss drug juggernaut Roche has confirmed that it’s…




![high-contrast-[¹⁸f]sitate-pet/ct-imaging-maps-somatostatin-receptors-in-meningiomas](https://biotechgrid.com/wp-content/uploads/2026/08/44773-high-contrast-80821-pet-ct-imaging-maps-somatostatin-receptors-in-meningiomas.jpg)










